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Background:  Suicide  is one  of the  leading  causes  of  death  in bipolar  disorder  (BD);  violent  suicide  attempts
are  associated  with  the  highest  level of lethality.  We aimed  to evaluate  factors  related  to  the  risk  of violent
suicide in  a large  naturalistic  sample  of  patients  with  BD; in addition,  we  analyzed  the  rates  of  lifetime
suicide  attempts  and  the  variables  associated  with  suicidal  behavior.
Methods:  We  recruited  847  patients  with  BD.  Patients  were  grouped  according  to  whether  they  had  a  life-
time history  of suicide  attempts  and, among  suicide  attempters,  subjects  who  had  used  a  violent  suicide
method  were  compared  with  those  who  had  attempted  suicide  with  a nonviolent  method.  Comparisons
were  performed  using  !2 tests  for categorical  variables  and  ANOVA  for continuous  variables.  Logistic
regression  (LogReg)  was  used  to identify  explanatory  variables  associated  with  violent  suicide  attempts
(dependent  variable).
Results: Two  hundred  and  two  patients  (24%)  had  a  lifetime  history  of suicide  attempts.  Subjects  with  at
least  one  lifetime  suicide  attempt  showed  longer  duration  of illness  (22.4 ±  14.1  years  vs 19.9 ±  14.2  years:
p  0.028),  more  lifetime  hypomanic  episodes  (3.3  ± 4.3  vs  2.3  ±  3.1:  p 0.001),  more  lifetime  depressive
episodes  (6.0  ±  4.4  vs  4.7 ± 4.1: p <  0.001),  higher  rates  of  lifetime  psychiatric  comorbidities  (50.0%  vs
41.3%:  p  0.029),  higher  rates  of lifetime  medical  comorbidities  (58.0%  vs  48.9%:  p  0.028)  and  higher  rates
of  reduced  HDL  cholesterol  (46.2%  vs 36.7%:  p 0.030).  Among  suicide  attempters,  fifty-two  patients  (30.6%)
attempted  suicide  with  a  violent  method.  We  found  more  men  in  the  group  of violent  suicide  attempters
than  in  the  group  of nonviolent  suicide  attempters  (65%  vs  28%;  p:  <0.001).  Moreover  subjects  with
previous  violent  attempts  showed  higher  mean  values  of  weight  (80.5  ±  18.3  vs  69.4  ± 14.7: p  < 0.001),
body  mass  index  (27.8  ± 5.6 vs  25.2  ± 4.7:  p <  0.003)  and  waist  circumference  (98.7  ±  18.5  vs  92.4  ± 14.3:
p  0.032).  The  LogReg  analysis  confirmed  the association  of  violent  attempts  with  male  gender  (p: <0.001;
Phi:  0.35)  and higher  waist  circumference  (p: <0.001;  Cohen’s  d:  0.39).
Limitations:  In  our research  we  analyzed  lifetime  suicide  attempts,  but the  sample  does  not  include  com-
pleted  suicides,  meaning  that we are  unable  to test  whether  the  results  are  generalizable  to  suicide
deaths.  Moreover,  some  relevant  variables,  such  as medical  comorbidities/metabolic  parameters  at  the
time of suicide  attempts  and  previous  medication,  were  not collected.  Another  limitation  concerns  the
heterogeneity  of recruited  patients  in  terms  of clinical  characteristics  (e.g.:  medical  conditions,  drug
treatments),  with  potential  confounding  factors.
Conclusions:  The  present  study  confirms  the  association  between  male  gender  and  violent  suicide  and
suggests  a  correlation  between  obesity  and  the  use  of  violent  suicide  methods.  The  relationship  between
obesity  and  suicidal  behaviour  is worthy  of interest  and  deserves  to be  explored  by further  studies.
©  2019  The  Authors.  Published  by Elsevier  Inc. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Bipolar disorder (BD) is a recurrent and chronic disease charac-
terized by the occurrence of manic (or hypomanic), depressive, or
mixed episodes. According to the World Health Organization, BD is
one of the world’s ten most disabling conditions [1]. Suicide is one
of the leading causes of death in BD: as reported by the most recent
https://doi.org/10.1016/j.comppsych.2019.152136
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guidelines [2], approximately 6%–7% of identified patients with BD
dies by suicide, 43% report suicidal ideation, 21% suicide plan and
16% suicide attempt within the past year. Existing studies suggest
that 13.2%–17.5% of patients with BD with a lifetime history of sui-
cide attempt performs them with violent methods, such as hanging,
shooting or jumping from heights; these subjects, despite repre-
senting a minority, need to be precociously recognised, as these
methods are associated with the highest level of lethality [3].
An extensive literature has deepened socio-demographic, clin-
ical, environmental, genetic and neurobiological factors related
to violent suicide methods in psychiatric disorders [4]. It has
been well established that men  use violent methods more often
than women, both in suicide and suicide attempts [5,6]. Fur-
thermore, higher impulsivity and aggression levels as well as
substance abuse disorder have been associated with violent sui-
cide [7–10]. A few studies investigated the correlation between
violent suicide and environmental factors, including seasonality,
temperature, relative humidity, rainfall, hours of sunshine and
pressure. A significant positive correlation was found between
violent attempts and ambient temperature and number of sun-
shine hours [11,12]. Recent research works deepened the relation
between violent suicide and serotonin axis, including candidate
gene studies and gene expression studies. In a candidate gene study
with a sample of schizophrenic patients, a significant association
was found between violent suicide and the genotype frequen-
cies of promoter of the serotonin-transporter gene (5HTTLPR)
polymorphism [13]. Other studies evaluated differences in the
promoter polymorphism of the tryptophane hydroxylase (TPH)
between violent and nonviolent suicide attempters, with conflict-
ing results [14,15]. In order to identify neurobiological factors
related to violent suicide, the implication of cytokines in the patho-
genesis of suicide has been recently investigated. Interleukin-6,
measured in cerebrospinal fluid (CSF), peripheral blood, and post-
mortem brain tissue, has shown robust associations with violent
suicide and suicide completion [16]. Furthermore, the relation-
ships between metabolic parameters and violent suicide have
been extensively studied. A study conducted by Tanskanen and
colleagues demonstrated that serum total cholesterol concentra-
tion was positively related to violent but not nonviolent suicide;
the same trend could be shown for the concentration of high
density lipoprotein cholesterol, but not reaching statistical signif-
icance [17]. Conversely, two studies performed by Marcincko and
colleagues found significantly lower cholesterol serum levels in vio-
lent suicide attempters compared with suicide attempters using
nonviolent methods [18,19]. A similar case-control study looked at
women with a history of suicide attempts and compared the serum
cholesterol concentration between violent suicide attempters and
nonviolent suicide attempters: again, a lower concentration was
predictive of violent methods within this sample of patients [20].
Two postmortem studies, relevant to the question of fatty acid
composition and violent suicide, reported the following findings:
significantly lower cholesterol levels in the prefrontal cortex of
violent suicide attempters, significantly higher cholesteryl ester
hydrolase (LIPA) expression in violent suicide attempters, a signifi-
cantly lower cholesterol/phospholipid level ratio in violent suicide
attempters and increased levels of phospholipids in violent suicide
attempters when compared with nonviolent suicide attempters
[21,22].
Risk factors for violent suicide, with special reference to BD,
were investigated by few studies, mainly conducted with small
samples and heterogeneous methods. Available data suggest that
male gender [23–25], onset of BD with a hypo/manic episode
[26,27], S allele of the serotonin transporter gene (5-HTTLPR) poly-
morphisms [26] and single nucleotide polymorphisms of the CLOCK
and TIMELESS genes [27] seem to be correlated with an increased
risk of suicide with violent methods. A study performed by our
research group analyzed the correlation between metabolic syn-
drome, lipid profile and suicide with violent methods in bipolar
patients, but no significant differences were found in violent suicide
attempters compared to nonviolent ones [28].
The primary goal of this study was  to evaluate in a large natural-
istic sample of patients with BD potential factors related to the risk
of suicide with violent methods. In addition, we sought to exam-
ine in our sample the rates of lifetime suicide attempts and the
variables associated with suicidal behavior.
2. Material and methods
2.1. Study design and patients
Data derive from an independent cross-sectional observational
study aimed to analyze course characteristics, medical conditions
and response to treatments in patients with BD.
Subjects for this study were recruited from all patients with a
principal diagnosis of BD type I, II or Not Otherwise Specified (NOS)
(DSM-IV-TR, DSM-5) [29,30] consecutively admitted to the Depart-
ment of Neuroscience, University of Turin (Italy), from January 2006
to February 2019.
Potential participants were thoroughly explained aims and
study procedures and had to give their written consent before
participation; exclusion criteria included age <18 and refusal to
consent participating in the study. The protocol was  approved by
the local Ethical Committees.
2.2. Assessments and procedures
All diagnoses were confirmed by means of the Mini-
International Neuropsychiatric Interview (MINI) [31]. At the study
entry, general socio-demographic information and clinical data
were collected for each subject. Clinical characteristics such as age
at onset, duration of illness, number of previous manic/depressive
episodes, psychiatric comorbidity, psychiatric family history, cur-
rent medication and psychopharmacological treatments were
ascertained either from clinical charts or by direct questioning
the study participants. History of suicide attempt, defined as a
selft–destructive behavior with the intention of ending one’s life,
independently of the resulting damage, [32] was retrospectively
assessed for each patient, focusing on the modality of suicidal
behavior. According to Stenbacka et al. [33], the suicide attempt
method was defined violent (hanging, shooting, jumping from
heights, moving train, cutting, drowning) or nonviolent (poison-
ing). Individuals who had made more than one attempt were
classified according to the violence of their most violent attempt.
All subjects received a medical examination; a specific evalua-
tion of metabolic parameters has been conducted for each patient:
weight was measured fasting and undressed, height barefoot, waist
circumference at midway between the inferior margin of the ribs
and the superior border of the iliac crest, at minimal inspiration.
Body mass index (BMI) was  calculated as the body weight in kilo-
grams divided by the square of the body height in metres. Two
blood pressure measurements were obtained by using a mercury
sphygmomanometer: the first with the subject in a lying position,
the second with the subject in a seated position at least two min-
utes after the first measurement. The mean blood pressure of the
two measurements was  used. A blood sample (including choles-
terol, glucose, triglycerides and HDL-c) was  drawn in the morning
(7:00 am), when patients were fasting for previous 10 h. Metabolic
syndrome has been evaluated using definition of the International
Diabetes Federation (IDF) Task Force on Epidemiology and Pre-
vention, American Heart Association and National Heart, Lung and
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Table  1
Socio-demographic and clinical characteristics of the total sample (n = 842) and differences in socio-demographic and clinical characteristics between suicide attempters
(n  = 202) and non attempters (n = 640).
Characteristics Total sample
(n = 842)
Suicide attempters
(n = 202)
Non-suicide
attempters (n = 640)
F/!2 df p
Age (years), mean ± sd 49.9 ± 15.7 50.8 ± 14.7 49.6 ± 16.0 1.017 1 0.313
Education (years), mean ± sd 11.9 ± 4.2 11.8 ± 4.1 11.9 ± 4.2 0.184 1 0.668
Sex,  n (%)
Male 348 (41.3) 77 (38.1) 271 (42.3) 1.130 1 0.288
Female 494 (58.7) 125 (61.9) 369 (57.7)
Bipolar disorder, type, n (%)
Bipolar I 352 (41.8) 73 (36.1) 279 (43.6) 5.072 4 0.280
Bipolar II 459 (54.5) 123 (60.9) 336 (52.5)
Bipolar NOS 28 (3.3) 6 (3.0) 22 (3.4)
Age of onset (years), mean ± sd 29.3 ± 12.4 28.4 ± 11.8 29.6 ± 12.6 1.528 1 0.217
Duration of illness (years), mean ± sd 20.5 ± 14.2 22.4 ± 14.1 19.9 ± 14.2 4.858 1 0.028
Duration of untreated illness (years), mean ± sd 13.2 ± 12.5 14.3 ± 13.0 12.9 ± 12.4 1.804 1 0.180
Manic episodes (number), mean ± sd 1.3 ± 2.5 1.0 ± 2.1 1.4 ± 2.6 3.154 1 0.077
Hypomanic episodes (number), mean ± sd 2.6 ± 3.4 3.3 ± 4.3 2.3 ± 3.1 11.965 1 0.001
Depressive episodes (number), mean ± sd 5.0 ± 4.2 6.0 ± 4.4 4.7 ± 4.1 13.741 1 <0.001
Lifetime psychiatric comorbidities, n (%) 365 (43.3) 101 (50.0) 264 (41.3) 4.787 1 0.029
Family history of mood disorders, n (%) 483 (57.6) 119 (59.2) 364 (57.1) 0.266 1 0.606
Family history of suicide, n (%) 11 (6.5) 3 (6.4) 8 (7.7) 0.080 1 0.774
Lifetime medical comorbidity, n (%) 402 (51.1) 112 (58.0) 290 (48.9) 4.855 1 0.028
Weight (kg), mean ± sd 72.6 ± 16.0 72.6 ± 16.6 72.6 ± 15.8 0.001 1 0.974
BMI  (kg/m2), mean ± sd 28.5 ± 5.8 25.8 ± 5.1 29.5 ± 5.2 0.386 1 0.535
Waist circumference (cm), mean ± sd 94.2 ± 16.7 94.6 ± 16.1 94.1 ± 16.9 0.071 1 0.790
Serum lipid levels (mg/dl), mean ± sd
Cholesterol 195.2 ± 44.7 193.5 ± 46.1 195.8 ± 44.2 0.290 1 0.591
Tryglicerides 134.2 ± 77.5 135.3 ± 85.4 133.8 ± 74.7 0.046 1 0.829
HDL  cholesterol 51.9 ± 16.5 51.2 ± 18.1 52.1 ± 15.9 0.358 1 0.550
Glycemia (mg/dl), mean ± sd 86.4 ± 22.8 88.1 ± 23.0 85.9 ± 22.8 1.214 1 0.271
Systolic arterial pressure (mmHg), mean ± sd 122.9 ± 12.5 122.1 ± 12.5 123.2 ± 12.5 1.006 1 0.316
Diastolic arterial pressure (mmHg), mean ± sd 79.1 ± 8.8 77.9 ± 8.7 79.4 ± 8.8 3.794 1 0.052
Metabolic syndrome, n (%) 198 (29.3) 58 (33.1) 140 (28.0) 1.654 1 0.198
Abdominal obesity, n (%) 259 (49.4) 73 (51.4) 186 (48.7) 0.306 1 0.580
Low  HDL cholesterol, n (%) 256 (39.1) 78 (46.2) 178 (36.7) 4.701 1 0.030
Elevated blood pressure, n (%) 321 (47.9) 85 (48.6) 236 (47.7) 0.387 1 0.824
Impaired fasting glucose, n (%) 117 (17.5) 37 (21.5) 80 (16.1) 2.876 1 0.237
Hypertriglyceridemia, n (%) 194 (29.1) 46 (26.7) 148 (29.9) 1.361 1 0.715
NOS: Not Otherwise Specified.
BMI: Body Mass Index.
Bold values indicate statistically significant values.
Blood Institute [34]: metabolic syndrome was present if three or
more of the following five criteria were met:
• Abdominal obesity: waist circumference ≥94 cm in men  and
≥80 cm in women;
• High blood pressure: systolic pressure ≥130 mmHg  and/or dias-
tolic pressure ≥85 mmHg  or on antihypertensive medication;
• High fasting glucose: ≥100 mg/dl or on glucose-lowering medi-
cation;
• Hypertriglyceridemia: ≥150 mg/dl or on lipid-lowering medica-
tion;
• Low HDL-C: <40 mg/dl in men  and <50 mg/dl in women.
2.3. Statistical analysis
Socio-demographic and clinical features of the patients were
summarized as mean and standard deviation (SD) for continuous
variables and frequency and percentage for categorical variables.
Patients were grouped according to whether they had a lifetime his-
tory of suicide attempts or they had never attempted suicide in their
life. Further, patients who had used a violent suicide method were
compared with those who had attempted suicide with a nonviolent
method.
The normality of data distribution was evaluated by using
Shapiro-Wilk and Kolmogorov-Smirnov tests. Comparisons were
performed using !2 tests for categorical variables and ANOVA
for continuous variables. Furthermore, logistic regression (LogReg)
was used to identify explanatory variables associated with violent
suicide attempts (dependent variable).
The results from every statistical comparison of the treatment
groups were presented as 2-sides p values rounded to 3 decimal
places. The criterion for statistical significance in all comparison
was a p value < 0.05.
All statistical analyses were performed by SPSS software version
22.0.
3. Results
Eight-hundred fifty-three patients with BD were asked to partic-
ipate; six refused their consent. Among the 847 patients recruited,
5 (0.6%) were excluded from the research due to lack of data about
lifetime suicide attempts.
Ultimately, we  completed the analysis using 842 subjects. The
demographic and clinical characteristics of the total sample are
given in Table 1. The sample is representative for the population
of patients with BD: 58.7% of the patients were females, the major-
ity of the sample (54.5%) had bipolar II disorder, the mean age at
onset of BD was 29.3 ± 12.4 years, the mean duration of illness
was 20.5 ± 14.2 years. Two hundred and two patients (24%) had a
lifetime history of suicide attempts; among suicide attempters, 22
subjects (10.9%) had made more than one attempt in their life. The
demographic and clinical differences between suicide attempters
and non attempters are summarized in Table 1: subjects with at
least one lifetime suicide attempt showed longer duration of ill-
ness (22.4 ± 14.1 years vs 19.9 ± 14.2 years: p 0.028), more lifetime
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Table  2
Differences in socio-demographic and clinical characteristics between violent (n = 52) and nonviolent (n = 118) suicide attempters.
Characteristics Violent attempt (n = 52) Nonviolent attempt (n = 118) F/!2 df p
Age (years), mean ± sd 49.9 ± 15.9 50.2 ± 14.1 0.062 1 0.831
Education (years), mean ± sd 11.8 ± 3.8 11.5 ± 4.1 0.179 1 0.673
Sex,  n (%)
Male 34 (65.4) 33 (28.0) 21.16 1 <0.001*
Female 18 (34.6) 85 (72.0)
Bipolar disorder, type, n (%)
Bipolar I 17 (32.7) 44 (37.3) 0.69 2 0.707
Bipolar II 34 (65.4) 70 (59.3)
Bipolar NOS 1 (1.9) 4 (3.4)
Age of onset (years), mean ± sd 28.7 ± 13.7 27.9 ± 11.5 0.138 1 0.711
Duration of illness (years), mean ± sd 21.3 ± 14.3 22.4 ± 13.6 0.222 1 0.638
Duration of untreated illness (years), mean ± sd 14.7 ± 14.3 14.7 ± 12.9 0.001 1 0.976
Manic episodes (number), mean ± sd 0.8 ± 1.5 1.2 ± 2.3 0.839 1 0.361
Hypomanic episodes (number), mean ± sd 3.1 ± 3.8 3.1 ± 4.5 0.001 1 0.994
Depressive episodes (number), mean ± sd 5.7 ± 4.0 6.2 ± 4.8 0.460 1 0.499
Lifetime psychiatric comorbidity, n (%) 23 (44.2) 56 (47.4) 0.151 1 0.697
Family history of mood disorders, n (%) 28 (53.8) 71 (60.7) 0.69 1 0.405
Family history of suicide, n (%) 3 (6.4) 8 (7.7) 0.080 1 0.774
Current psychopharmacological treatment, n (%)
Monotherapy 6 (11.5) 21 (17.8)
Combination therapy 45 (88.5) 97 (82.2) 3.240 2 0.198
None  1 (1.9) 0 (0)
Lithium, n (%) 31 (59.6) 76 (65.0) 0.442 1 0.506
Anticonvulsivants, n (%) 27 (51.9) 53 (44.9) 0.771 1 0.399
First-generation antipsychotics, n (%) 8 (15.4) 7 (5.9) 4.009 1 0.074
Second-generation antipsychotics, n (%) 30 (57.7) 60 (50.8) 0.679 1 0.410
Antidepressants, n (%) 19 (36.5) 48 (40.7) 0.259 1 0.611
Lifetime medical comorbidity, n (%) 32 (61.5) 70 (59.3) 0.044 1 0.083
Weight (kg), mean ± sd 80.5 ± 18.3 69.4 ± 14.7 16.6 1 <0.001*
BMI  (kg/m2), mean ± sd 27.8 ± 5.6 25.2 ± 4.7 9.34 1 0.003*
Waist circumference (cm), mean ± sd 98.7 ± 18.5 92.4 ± 14.3 0.968 1 0.032*
Serum lipid levels (mg/dl), mean ± sd
Cholesterol 190.6 ± 49.2 194.6 ± 45.0 0.234 1 0.629
Tryglicerides 154.2 ± 95.1 131.6 ± 83.2 2.272 1 0.134
HDL  cholesterol 47.6 ± 15.4 52.0 ± 18.9 1.955 1 0.164
Glycemia (mg/dl), mean ± sd 89.1 ± 23.8 86.9 ± 23.3 0.296 1 0.587
Systolic arterial pressure (mmHg), mean ± sd 124.1 ± 11.9 120.8 ± 12.4 2.529 1 0.114
Diastolic arterial pressure (mmHg), mean ± sd 78.9 ± 8.8 77.5 ± 8.8 0.958 1 0.327
Metabolic syndrome, n (%) 20 (35.7) 36 (64.3) 1.13 1 0.288
Abdominal obesity, n (%) 21 (40.4) 49 (41.5) 1.704 1 0.300
Low  HDL cholesterol, n (%) 19 (36.5) 54 (45.8) 0.605 1 0.437
Elevated blood pressure, n (%) 27 (51.9) 50 (42.4) 1.006 1 0.316
Impaired fasting glucose, n (%) 12 (23.1) 20 (16.9) 0.789 1 0.374
Hypertriglyceridemia, n (%) 13 (25.0) 31 (26.3) 0.124 1 0.724
NOS: Not Otherwise Specified.
BMI: Body mass index.
* Remained significant after Bonferroni correction: p < 0.0017.
Table 3
Relationship between potential explanatory variables and violent suicide methods: results from the logistic regression analysis.
Dependent variables B S.E. Wald ORa 95% CI OR p
Gender (Male) 1.820 0.545 11.147 6.174 (2.121-17.972) 0.001
Body  weight −0.002 0.033 0.004 0.998 (0.935-1.065) 0.948
Body  Mass Index 0.086 0.096 0.807 1.090 (0.903-1.315) 0.369
Abdominal circumference −0.037 0.018 4.309 0.964 (0.931-0.998) 0.036
Bold values indicate statistically significant values.
hypomanic episodes (3.3 ± 4.3 vs 2.3 ± 3.1: p 0.001), more lifetime
depressive episodes (6.0 ± 4.4 vs 4.7 ± 4.1: p < 0.001), higher rates of
lifetime psychiatric comorbidities (50.0% vs 41.3%: p 0.029), higher
rates of lifetime medical comorbidities (58.0% vs 48.9%: p 0.028)
and higher rates of reduced HDL cholesterol (46.2% vs 36.7%: p
0.030).
The suicide attempters’ group was further analyzed according
to whether they had employed a violent or a nonviolent sui-
cide attempt; within the attempters’ group 32 subjects (15.8%)
were excluded due to lack of data about the modality of suici-
dal behavior. The results are shown in Table 2. Fifty-two patients
(30.6%) attempted suicide with a violent method. Violent sui-
cidal attempts consisted respectively in jumping from heights
(n = 17), hanging (n = 13), abdominal knife wounds (n = 7), gun-
shot wounds (n = 4), gas poisoning (n = 4), car accident (n = 3),
others (n = 4). In our sample, nonviolent method was  drug over-
dose (n = 118). There was a statistically significant difference in
sex distribution (p: <0.001), with more men  in the group of vio-
lent suicide attempters than in the group of nonviolent suicide
attempters (65% vs 28%; p: <0.001). Moreover, we  found sig-
nificant differences within metabolic parameters: subjects with
previous violent attempts, in comparison to patients with nonvio-
lent attempts, showed higher mean values of weight (80.5 ± 18.3
vs 69.4 ± 14.7: p < 0.001), BMI  (27.8 ± 5.6 vs 25.2 ± 4.7: p < 0.003)
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and waist circumference (98.7 ± 18.5 vs 92.4 ± 14.3: p 0.032).
There were no further significant differences within other socio-
demographic and clinical characteristics between the two groups.
The LogReg analysis confirmed the association of violent attempts
with male gender (p: <0.001; Phi: 0.35) and with higher waist
circumference (p: <0.001; Cohen’s d: 0.39). The results of the
LogReg analysis are described in Table 3; independent variables
included were gender, BMI, weight, abdominal circumference.
The LogReg model was statistically significant, !2 (4) = 29.590,
p < .001. The model explained 28.0% (Nagelkerke R2) of the vari-
ance in response and correctly classified 71.6% of cases. Since the
LogReg ruled out weight and BMI  as independent risk factors,
monovariate analyses have been conducted in gender subgroups.
In male subgroup no differences emerged between violent and
nonviolent suicide attempters; in female subgroup there are
statistically significant differences between violent and nonvio-
lent suicide attempters in terms of higher mean body weight
(73,2 kg ± 14,5 vs 65,65 ± 12,9: p = .034) and BMI  (27,7 ± 4,3 vs
25,1 ± 4,9: p = .047).
4. Discussion
The main objective of this study was to analyze socio-
demographic and clinical factors related to violent suicide attempts
in a large naturalistic sample of patients with BD; in addition, we
analyzed the rates of lifetime suicide attempts and the variables
associated with suicidal behavior.
The prevalence of lifetime suicide attempts found in our sam-
ple (24%) is consistent with those reported by previous studies
[35–37]. Some clinical variables (longer duration of illness, more
lifetime hypomanic and depressive episodes, higher rates of life-
time psychiatric and medical comorbidities) were showed to be
associated with greater likelihood of lifetime suicide attempts:
these results were expected and confirm the most important
studies recently carried out on this topic [38,37]. Furthermore, a
correlation emerged between reduced HDL cholesterol and lifetime
suicide attempts: to date, two studies reported lower serum total
cholesterol levels in BD patients with history of suicide attempt
[38,39], while no association was identified in a previous Italian
study [28]. Therefore, our finding is noteworthy and deserve further
investigation in future studies.
In our sample about one-third of patients (30.6%) with his-
tory of suicidal behavior used violent methods, while previous
studies showed lower rates of violent suicide attempts in BD
(13.2%–17.5%) [40,41,28]. There are possible explanations for the
lack of correspondence between our results and available liter-
ature data. Firstly, the sample consists of patients with a high
severity of illness, as our Department is a tertiary referral cen-
ter located within the University General Hospital. Furthermore,
investigations on suicidal behaviors in BD, including the present
study, are heterogeneous, in terms of characteristics of the sam-
ples (e.g.: medications, psychiatric comorbidities), instruments
used to assess suicidality and definition of violent or nonviolent
methods. Comparing the subjects according to whether they had
employed a violent or a nonviolent suicide method, we found sig-
nificant differences across gender, with more men  in the group
of violent suicide attempters. Our result is consistent with previ-
ous studies that have demonstrated that the main differences in
suicidal behavior between men  and women is the method cho-
sen to attempt suicide [23,24,28]. No further differences regarding
socio-demographic and psychopathological features were found
between the two groups. Concerning medical comorbidities and
metabolic disorders, our results showed higher mean values of
weight, BMI  and waist circumference in the group of violent sui-
cide attempters, while no significant difference was  found in terms
of serum lipid levels, glycemia, blood pressure and metabolic
syndrome. The LogReg analysis confirmed also abdominal circum-
ference as independent variable associated with violent suicide
attempts; results from monovariate analyses conducted in gen-
der subgroups showed in female group higher mean body weight
and BMI  values in violent attempters. To our knowledge only one
previous study, performed by our research group, with a smaller
sample size, specifically evaluated the correlation between violent
suicide attempts and metabolic parameters in BD: the results did
not show any significant difference between violent and nonvio-
lent suicide attempters. [28]. The methodological limitations of the
present study, discussed in the following paragraph, make it dif-
ficult to interpret the association between higher BMI/abdominal
obesity and violent suicide methods: data on metabolic parame-
ters at the time of suicide attempts and previous pharmacological
treatments would be needed to distinguish whether BMI  and waist
circumference may  directly influence the use of violent methods
or whether subjects with history of violent attempts are more
likely to be prescribed medication that leads to weigth gain and
abdominal obesity (e.g.: second generation antipsychotics). The
hypothesis of a causal relationship between obesity and violent
suicide methods could be explained by the association between
obesity and impulsivity. Indeed, impulsive personality traits are
prevalent characteristics in obese BD patients and some studies
suggest that obesity and impulsivity together may  lead to severe
course of illness and worse prognosis [42]. Therefore, the relation-
ship between obesity and suicidal behaviour is worthy of interest
and deserves to be explored by further methodologically rigorous
studies.
Our study presents several limitations, mostly due to the cross-
sectional design and to the fact that data derives from a study
aimed to investigate clinical characteristics of BD and not suici-
dal behavior specifically. First, in our research we  analyzed lifetime
suicide attempts, but the sample does not include completed sui-
cides, meaning that we  are unable to test whether the results
are generalizable to suicide deaths; then suicidal intent to die
is difficult to ascertain retrospectively and information could be
biased. Moreover, some patients have missing data about the
modality of suicidal attempts and some relevant variables, such
as medical comorbidities and metabolic parameters at the time
of suicide attempts. Furthermore, in our analysis the impact of
pharmacological treatment on suicidal behavior and on metabolic
parameters was  not evaluated, due to the lack of data on med-
ications prior to study entry. Another limitation concerns the
heterogeneity of recruited patients in terms of clinical character-
istics (e.g.: medical conditions, drug treatments), with potential
confounding factors.
Instead, the large sample size is a strength of the study. Fur-
thermore, subjects enrolled for this study were representative of
“real-world” in and outpatients with BD: this should be consid-
ered a point of strength in terms of generalizability and external
validity.
5. Conclusions
In conclusion, the present study confirms the association
between male gender and violent suicide; moreover, our findings
suggest a correlation between obesity and the use of violent sui-
cide methods, especially in female patients, but further research
is awaited to explore and clarify this relationship. Considering that
suicide is regrettably frequent in patients with BD future studies on
this issue could help detecting individuals at risk of suicide attempt
and take appropriate actions as early as possible.
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